Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Paracelsian Inc (PRLN) -- Ignore unavailable to you. Want to Upgrade?

To: John H. Farro who wrote (4165)	2/4/1999 9:03:00 AM
From: John H. Farro	Read Replies (1) \| Respond to of 4342

Leo, is there any chance that you will inform your readers of recent PRLN developments in an upcoming issue of your newsletter? Judging from past performance, I would say that the readers of your newsletter alone can't move the price of the stock, but if we get more newsletters with wider circulations to pick up on the PRLN story we might see some major movement. Robin

To: John H. Farro who wrote (4165)	2/5/1999 6:36:00 PM
From: A.R.Venkatesh	Read Replies (1) \| Respond to of 4342

Robin, I think you may be right about prdeiction (3). But I would put it 50/50 because it is binary in nature, either it happens or it does not happen. It may not happen because large pharmaceuticals are not interested in replacing(revenues of) multi-drug therapies with that of a single one(if that is the case). If I recollect correctly Paracelsian's drug works in conjunction with other drugs. Anyway we have SRI on Paracelsian's side and more importantly Travellers Insurance(an investor) will be very interested in getting remedial therapy to the AIDS virus. I believe that Travellers insurance together with SRI & Paraclesian can influence a major Pharmaceutical to sign on. I think this solution has already been proven once